News
RDHL
0.6325
+8.86%
0.0515
Weekly Report: what happened at RDHL last week (0803-0807)?
Weekly Report · 1d ago
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 4d ago
RedHill Biopharma Reschedules Quorum-Delayed AGM to August 7
TipRanks · 5d ago
Weekly Report: what happened at RDHL last week (0727-0731)?
Weekly Report · 08/03 10:00
RedHill Biopharma Advances Opaganib as Ebola Outbreak Worsens
TipRanks · 07/28 11:28
Ebola Cases and Deaths Rapidly Mount - RedHill Updates on Opaganib Emergency Outbreak Development
PR Newswire · 07/28 11:00
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 07/27 21:06
Weekly Report: what happened at RDHL last week (0720-0724)?
Weekly Report · 07/27 10:03
Weekly Report: what happened at RDHL last week (0713-0717)?
Weekly Report · 07/20 10:00
Weekly Report: what happened at RDHL last week (0706-0710)?
Weekly Report · 07/13 10:02
Weekly Report: what happened at RDHL last week (0629-0703)?
Weekly Report · 07/06 10:05
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 07/01 12:05
RedHill Biopharma Reschedules 2026 AGM to Add Proposal, Seeks Approval to Scrap Par Value
TipRanks · 07/01 11:27
RedHill Biopharma Expands ATM ADS Offering Capacity in U.S. Market
TipRanks · 06/29 11:28
Weekly Report: what happened at RDHL last week (0622-0626)?
Weekly Report · 06/29 10:01
RedHill Biopharma Sets July 28, 2026 AGM to Vote on Board, Auditor and Chairman-CEO Role
TipRanks · 06/25 11:32
RedHill Biopharma Closes $6 Million Private Placement to Fund Potential Acquisition
TipRanks · 06/22 21:17
RedHill Biopharma Raises $6 Million in June 2026 Private Placement of ADSs and Warrants
TipRanks · 06/22 20:28
RedHill Biopharma Announces Closing of Up To $19.4 Million Private Placement
PR Newswire · 06/22 20:10
More
Webull provides a variety of real-time RDHL stock news. You can receive the latest news about Redhill Biopharm through multiple platforms. This information may help you make smarter investment decisions.
About RDHL
RedHill Biopharma Ltd is an Israel-based specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases. RedHill promotes the gastrointestinal drugs such as, Talicia for the treatment of Helicobacter pylori (H. pylori) infection, and Aemcolo, for the treatment of travelers’ diarrhea. RedHill’s clinical late-stage development programs include: :info: RHB-204, for pulmonary nontuberculous mycobacteria (NTM) disease; opaganib (ABC294640), host-directed, SPHK2 inhibitor targeting multiple indications, RHB-107 (upamostat), an oral, host-directed serine protease inhibitor with potential for pandemic preparedness, is in late-stage development for treatment of non-hospitalized symptomatic COVID-19, and is targeting multiple other cancer and inflammatory gastrointestinal diseases; RHB-104 for Crohn's disease; and RHB-102 for chemotherapy and radiotherapy induced nausea and vomiting.